V-ATPase 31, C-terminal is a peptide fragment derived from the vacuolar ATPase complex, useful for probing protein–protein interactions within proton-transport machinery. Its sequence highlights motifs involved in subunit assembly. Biochemical stability supports targeted binding analyses. The fragment is used to explore structural organization and regulatory coordination of V-ATPase components.
CAT No: S06075
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More